세계의 혈액 기반 바이오마커 시장 보고서(2025년)

Blood Based Biomarkers Global Market Report 2025

US $ 4,490 ￦ 6,233,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,010,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,786,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

혈액 기반 바이오마커 시장 규모는 향후 몇 년 동안 12.4%의 연평균 성장률로 2029년까지 415억 5,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 바이오마커 분석에서 AI 및 머신러닝의 확대, 질병 조기 발견에 대한 수요 증가, 원격의료 및 원격 진단의 성장, 만성질환의 유병률 증가, 소비자의 건강 인식 증가에 의해 주도될 것으로 보입니다. 이 기간의 주요 동향으로는 AI를 활용한 바이오마커 탐색, 액체 생검의 발전, 멀티오믹스 통합, 현장진단(POC) 검사기기 개발, 차세대 염기서열분석(NGS) 혁신 등이 있습니다.

심혈관질환의 유병률 증가는 혈액 기반 바이오마커 시장의 성장을 촉진할 것으로 예상됩니다. 심혈관질환은 관상동맥질환, 심부전, 뇌졸중 등 심장과 혈관에 영향을 미치는 질환을 포함하며, 식습관 장애 및 비만율 증가와 같은 위험 요인으로 인해 더욱 보편화되고 있습니다. 혈액 기반 바이오마커는 혈액 내 측정 가능한 물질을 통해 질병의 진행, 위험 평가, 치료 반응에 대한 귀중한 정보를 제공함으로써 이러한 질병의 진단 및 모니터링에 중요한 역할을 하고 있습니다. 2024년 9월 국립생명공학정보센터(National Center for Biotechnology Information)가 실시한 세계 건강 조사 이니셔티브에 따르면 2025-2050년까지 심혈관 질환 환자가 90% 증가하고, 심혈관 질환으로 인한 사망자 수는 2050년까지 3,560만 명에 이를 것으로 예측하고 있습니다. 이러한 심혈관질환의 유병률 증가가 혈액 기반 바이오마커 시장의 성장에 기여하고 있습니다.

혈액 기반 바이오마커 시장의 주요 기업들은 알츠하이머병 등의 진단에 도움이 되는 고정밀 혈액 바이오마커 검사와 같은 기술 혁신에 집중하고 있습니다. 이러한 검사는 혈액 내 특정 바이오마커를 활용하여 높은 정확도와 신뢰성으로 건강 상태를 감지하거나 모니터링합니다. 예를 들어, 미국 생명과학 기업 퀀테릭스(Quanterix)는 2023년 10월, 의사가 인지기능 장애가 있는 성인의 알츠하이머병 진단을 돕기 위해 고안된 고정밀 혈액 바이오마커 검사인 LucentAD p-Tau 217 검사를 발표하였습니다. 이 검사는 알츠하이머병의 병태, 특히 뇌 내 아밀로이드 축적과 밀접한 연관이 있는 트레오닌 217로 인산화 된 타우 단백질(p-Tau 217)을 측정하는 검사로, 90% 이상의 정확도를 제공하며, 엄격한 진단 기준을 충족하는 검사입니다. 단독이 아닌 다른 진단 도구와 병행하여 사용하도록 되어 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 혈액 기반 바이오마커 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업 분석
• 세계의 혈액 기반 바이오마커 시장 : 성장률 분석
• 세계의 혈액 기반 바이오마커 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 혈액 기반 바이오마커 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 혈액 기반 바이오마커 전체 시장(TAM)

제6장 시장 세분화

• 세계의 혈액 기반 바이오마커 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 유전자 바이오마커
• 단백질 바이오마커
• 대사 바이오마커
• 세포 기반 바이오마커
• 에피제네틱 바이오마커
• 세계의 혈액 기반 바이오마커 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 차세대 시퀀싱
• 중합효소 연쇄 반응
• 면역측정
• 질량 분석
• 기타
• 세계의 혈액 기반 바이오마커 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 암
• 심혈관질환
• 신경질환
• 면역질환
• 기타
• 세계의 혈액 기반 바이오마커 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 병원·클리닉
• 진단 검사실
• 연구·학술기관
• 기타
• 세계의 혈액 기반 바이오마커 시장 : 유전자 바이오마커 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 유전자 바이오마커
• 단백질 바이오마커
• 대사 바이오마커
• 세포 기반 바이오마커
• 에피제네틱 바이오마커
• 세계의 혈액 기반 바이오마커 시장 : 단백질 바이오마커 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 효소
• 호르몬
• 사이토카인
• 종양 마커
• 급성기 단백질
• 세계의 혈액 기반 바이오마커 시장 : 대사 바이오마커 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 지질 프로파일
• 아미노산 레벨
• 혈당치·젖산치
• 유기산
• 대사물 패널
• 세계의 혈액 기반 바이오마커 시장 : 세포 기반 바이오마커 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 순환종양세포(CTC)
• 면역 세포 프로파일링
• 줄기세포
• 혈소판
• 내피세포
• 세계의 혈액 기반 바이오마커 시장 : 에피제네틱 바이오마커 하위 세분화 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 데옥시리보핵산(DNA) 메틸화 패턴
• 히스톤 변형
• 비코드 리보핵산(RNA)
• 크로마틴 접근성
• 에피제네틱 효소 활성

제7장 지역별·국가별 분석

• 세계의 혈액 기반 바이오마커 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 혈액 기반 바이오마커 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 혈액 기반 바이오마커 시장 : 경쟁 구도
• 혈액 기반 바이오마커 시장 : 기업 개요
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
  • Eisai Co Ltd Overview, Products and Services, Strategy and Financial Analysis
  • Sysmex Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Exact Sciences Corporation Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Guardant Health
• Quanterix Corporation
• Illumina Inc
• QIAGEN NV
• GENFIT
• Foundation Medicine Inc
• Adaptive Biotechnologies Corporation
• GRAIL LLC
• Biodesix Inc
• Cleveland Diagnostics Inc
• Creative Diagnostics
• Epigenomics AG
• C2N Diagnostics
• Diadem srl
• Proteomedix AG

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 혈액 기반 바이오마커 시장 2029년 : 새로운 기회를 제공하는 국가
• 혈액 기반 바이오마커 시장 2029년 : 새로운 기회를 제공하는 부문
• 혈액 기반 바이오마커 시장 2029년 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Blood-based biomarkers are substances in the blood that can be measured to indicate the presence, progression, or response to a disease. They are primarily used for early detection, helping to personalize treatment plans and monitor treatment effectiveness with minimal invasiveness.

These biomarkers can be categorized into several types, including genetic, protein, metabolic, cell-based, and epigenetic biomarkers. Genetic biomarkers, which are based on DNA or RNA, identify genetic variations, mutations, or expression patterns linked to specific diseases or treatment responses. They are utilized in various advanced technologies, such as next-generation sequencing, polymerase chain reaction, immunoassays, and mass spectrometry. These biomarkers play a critical role in diagnosing and monitoring diseases such as cancer, cardiovascular conditions, neurological disorders, and immunological diseases. Key users of these biomarkers include hospitals, clinics, diagnostic labs, research institutes, and other healthcare providers.

The blood-based biomarkers market research report is one of a series of new reports from The Business Research Company that provides blood-based biomarkers market statistics, including the blood-based biomarkers industry global market size, regional shares, competitors with the blood-based biomarkers market share, detailed blood-based biomarkers market segments, market trends, and opportunities, and any further data you may need to thrive in the blood-based biomarkers industry. This blood-based biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The blood-based biomarkers market size has grown rapidly in recent years. It will grow from $23.13 billion in 2024 to $26.06 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth observed in the past can be attributed to the increasing global incidence of cancer, a higher adoption of personalized medicine, more funding in biomarker research, a rise in clinical trials involving biomarkers, and an increase in the approval of companion diagnostics.

The blood-based biomarkers market size is expected to see rapid growth in the next few years. It will grow to $41.55 billion in 2029 at a compound annual growth rate (CAGR) of 12.4%. The growth during the forecast period is expected to be driven by the expansion of AI and machine learning in biomarker analysis, a higher demand for early disease detection, the growth of telemedicine and remote diagnostics, the increasing prevalence of chronic diseases, and greater health awareness among consumers. Key trends during this period will include AI-driven biomarker discovery, advancements in liquid biopsy, integration of multi-omics, development of point-of-care (POC) testing devices, and innovations in next-generation sequencing (NGS).

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the blood-based biomarkers market. Cardiovascular diseases, which encompass disorders affecting the heart and blood vessels such as coronary artery disease, heart failure, and stroke, are becoming more common due to risk factors such as poor diet and rising obesity rates. Blood-based biomarkers play a crucial role in diagnosing and monitoring these diseases by offering valuable information on disease progression, risk assessment, and treatment response through measurable substances in the blood. A global health research initiative by the National Center for Biotechnology Information in September 2024 projected a 90% increase in cardiovascular disease cases from 2025 to 2050, with cardiovascular deaths expected to reach 35.6 million by 2050. This rising incidence of cardiovascular diseases is contributing to the market growth for blood-based biomarkers.

Leading companies in the blood-based biomarkers market are focusing on technological innovations, such as high-accuracy blood biomarker tests, to assist in diagnosing diseases such as Alzheimer's disease. These tests use specific biomarkers in the blood to detect or monitor health conditions with high precision and reliability. For example, in October 2023, Quanterix, a US-based life sciences company, introduced the LucentAD p-Tau 217 test, a high-accuracy blood biomarker test designed to help physicians diagnose Alzheimer's disease in adults with cognitive impairment. The test measures phosphorylated tau protein at threonine 217 (p-Tau 217), which is strongly linked to Alzheimer's pathology, particularly amyloid buildup in the brain. The LucentAD p-Tau 217 test provides over 90% accuracy, fulfilling stringent diagnostic criteria, and is meant to be used alongside other diagnostic tools rather than independently.

In December 2023, Danaher, a US-based provider of diagnostic, life sciences, and environmental solutions, acquired Abcam for $5.7 billion. This acquisition allows Danaher to enhance its life sciences portfolio by incorporating Abcam's leading protein consumables and research tools. Abcam, a UK-based life sciences company, specializes in the development and distribution of research tools, including antibodies, assays, and reagents.

Major players in the blood based biomarkers market are Siemens Healthineers AG, Agilent Technologies Inc, Eisai Co Ltd, Sysmex Corporation, Exact Sciences Corporation, Guardant Health, Quanterix Corporation, Illumina Inc, QIAGEN NV, GENFIT, Foundation Medicine Inc, Adaptive Biotechnologies Corporation, GRAIL LLC, Biodesix Inc, Cleveland Diagnostics Inc, Creative Diagnostics, Epigenomics AG, C2N Diagnostics, Diadem srl, Proteomedix AG.

North America was the largest region in the blood-based biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood-based biomarkers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blood-based biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood-based biomarkers market consists of revenues earned by entities by providing services such as clinical trial services, sample collection and biobanking services, custom biomarker assay development, data analysis and interpretation services, companion diagnostics services, point-of-care testing services, and regulatory and compliance support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood-based biomarkers market includes sales of diagnostic kits, reagents, assay platforms, analyzers, and related consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Based Biomarkers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood based biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood based biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood based biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Genetic Biomarkers; Protein Biomarkers; Metabolic Biomarkers; Cell-Based Biomarkers; Epigenetic Biomarkers
• 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Immunoassays; Mass Spectrometry; Other Technologies
• 3) By Application: Cancer; Cardiovascular Diseases; Neurological Diseases; Immunological Diseases; Other Applications
• 4) By End Users: Hospitals And Clinics; Diagnostic Laboratories; Research And Academic Institutes; Other End Users
• Subsegments:
• 1) By Genetic Biomarkers: Deoxyribonucleic Acid (DNA) Mutations; Ribonucleic Acid (RNA) Expression Profiles; Single Nucleotide Polymorphisms (SNPs); Copy Number Variations (CNVs); Gene Fusions
• 2) By Protein Biomarkers: Enzymes; Hormones; Cytokines; Tumor Markers; Acute Phase Proteins
• 3) By Metabolic Biomarkers: Lipid Profiles; Amino Acid Levels; Glucose And Lactate Levels; Organic Acids; Metabolite Panels
• 4) By Cell-Based Biomarkers: Circulating Tumor Cells (CTCs); Immune Cell Profiling; Stem Cells; Platelets; Endothelial Cells
• 5) By Epigenetic Biomarkers: Deoxyribonucleic Acid (DNA) Methylation Patterns; Histone Modifications; Non-Coding Ribonucleic Acid (RNA); Chromatin Accessibility; Epigenetic Enzyme Activity
• Companies Mentioned: Siemens Healthineers AG; Agilent Technologies Inc; Eisai Co Ltd; Sysmex Corporation; Exact Sciences Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Based Biomarkers Market Characteristics

3. Blood Based Biomarkers Market Trends And Strategies

4. Blood Based Biomarkers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Based Biomarkers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Blood Based Biomarkers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Blood Based Biomarkers Market Growth Rate Analysis
• 5.4. Global Blood Based Biomarkers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Blood Based Biomarkers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Blood Based Biomarkers Total Addressable Market (TAM)

6. Blood Based Biomarkers Market Segmentation

• 6.1. Global Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Biomarkers
• Protein Biomarkers
• Metabolic Biomarkers
• Cell-Based Biomarkers
• Epigenetic Biomarkers
• 6.2. Global Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Immunoassays
• Mass Spectrometry
• Other Technologies
• 6.3. Global Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cancer
• Cardiovascular Diseases
• Neurological Diseases
• Immunological Diseases
• Other Applications
• 6.4. Global Blood Based Biomarkers Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Laboratories
• Research And Academic Institutes
• Other End Users
• 6.5. Global Blood Based Biomarkers Market, Sub-Segmentation Of Genetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Biomarkers
• Protein Biomarkers
• Metabolic Biomarkers
• Cell-Based Biomarkers
• Epigenetic Biomarkers
• 6.6. Global Blood Based Biomarkers Market, Sub-Segmentation Of Protein Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzymes
• Hormones
• Cytokines
• Tumor Markers
• Acute Phase Proteins
• 6.7. Global Blood Based Biomarkers Market, Sub-Segmentation Of Metabolic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid Profiles
• Amino Acid Levels
• Glucose And Lactate Levels
• Organic Acids
• Metabolite Panels
• 6.8. Global Blood Based Biomarkers Market, Sub-Segmentation Of Cell-Based Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Circulating Tumor Cells (CTCs)
• Immune Cell Profiling
• Stem Cells
• Platelets
• Endothelial Cells
• 6.9. Global Blood Based Biomarkers Market, Sub-Segmentation Of Epigenetic Biomarkers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deoxyribonucleic Acid (DNA) Methylation Patterns
• Histone Modifications
• Non-Coding Ribonucleic Acid (RNA)
• Chromatin Accessibility
• Epigenetic Enzyme Activity

7. Blood Based Biomarkers Market Regional And Country Analysis

• 7.1. Global Blood Based Biomarkers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Blood Based Biomarkers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Based Biomarkers Market

• 8.1. Asia-Pacific Blood Based Biomarkers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Based Biomarkers Market

• 9.1. China Blood Based Biomarkers Market Overview
• 9.2. China Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Based Biomarkers Market

• 10.1. India Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Based Biomarkers Market

• 11.1. Japan Blood Based Biomarkers Market Overview
• 11.2. Japan Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Based Biomarkers Market

• 12.1. Australia Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Based Biomarkers Market

• 13.1. Indonesia Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Based Biomarkers Market

• 14.1. South Korea Blood Based Biomarkers Market Overview
• 14.2. South Korea Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Based Biomarkers Market

• 15.1. Western Europe Blood Based Biomarkers Market Overview
• 15.2. Western Europe Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Based Biomarkers Market

• 16.1. UK Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Based Biomarkers Market

• 17.1. Germany Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Based Biomarkers Market

• 18.1. France Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Based Biomarkers Market

• 19.1. Italy Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Based Biomarkers Market

• 20.1. Spain Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Based Biomarkers Market

• 21.1. Eastern Europe Blood Based Biomarkers Market Overview
• 21.2. Eastern Europe Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Based Biomarkers Market

• 22.1. Russia Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Based Biomarkers Market

• 23.1. North America Blood Based Biomarkers Market Overview
• 23.2. North America Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Based Biomarkers Market

• 24.1. USA Blood Based Biomarkers Market Overview
• 24.2. USA Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Based Biomarkers Market

• 25.1. Canada Blood Based Biomarkers Market Overview
• 25.2. Canada Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Based Biomarkers Market

• 26.1. South America Blood Based Biomarkers Market Overview
• 26.2. South America Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Based Biomarkers Market

• 27.1. Brazil Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Based Biomarkers Market

• 28.1. Middle East Blood Based Biomarkers Market Overview
• 28.2. Middle East Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Based Biomarkers Market

• 29.1. Africa Blood Based Biomarkers Market Overview
• 29.2. Africa Blood Based Biomarkers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Blood Based Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Blood Based Biomarkers Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Based Biomarkers Market Competitive Landscape And Company Profiles

• 30.1. Blood Based Biomarkers Market Competitive Landscape
• 30.2. Blood Based Biomarkers Market Company Profiles
  • 30.2.1. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Agilent Technologies Inc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Eisai Co Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sysmex Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Exact Sciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Blood Based Biomarkers Market Other Major And Innovative Companies

• 31.1. Guardant Health
• 31.2. Quanterix Corporation
• 31.3. Illumina Inc
• 31.4. QIAGEN NV
• 31.5. GENFIT
• 31.6. Foundation Medicine Inc
• 31.7. Adaptive Biotechnologies Corporation
• 31.8. GRAIL LLC
• 31.9. Biodesix Inc
• 31.10. Cleveland Diagnostics Inc
• 31.11. Creative Diagnostics
• 31.12. Epigenomics AG
• 31.13. C2N Diagnostics
• 31.14. Diadem srl
• 31.15. Proteomedix AG

32. Global Blood Based Biomarkers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Based Biomarkers Market

34. Recent Developments In The Blood Based Biomarkers Market

35. Blood Based Biomarkers Market High Potential Countries, Segments and Strategies

• 35.1 Blood Based Biomarkers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Blood Based Biomarkers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Blood Based Biomarkers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료